Raymond Hakim
Last active: 6/9/2014

  1. Recommendations for reducing the high morbidity and mortality of United States maintenance dialysis patients. The National Kidney Foundation. Kopple JD, Hakim RM, Held PJ, Keane WF, King K, Lazarus JM, Parker TF, Teehan BP (1994) Am J Kidney Dis 24(6): 968-73
    › Primary publication · 7985678 (PubMed)
  2. Initiation of dialysis. Hakim RM (1994) Adv Nephrol Necker Hosp : 295-309
    › Primary publication · 8154361 (PubMed)
  3. Hemodialysis membrane biocompatibility in acute renal failure. Schulman G, Hakim R (1994) Adv Ren Replace Ther 1(1): 75-82
    › Primary publication · 7641091 (PubMed)
  4. Endotoxin transfer during dialysis: less than meets the eye? Hakim RM (1994) J Lab Clin Med 124(6): 742-3
    › Primary publication · 7798782 (PubMed)
  5. Effects of dose of dialysis on morbidity and mortality. Hakim RM, Breyer J, Ismail N, Schulman G (1994) Am J Kidney Dis 23(5): 661-9
    › Primary publication · 8172208 (PubMed)
  6. Effect of the dialysis membrane in the treatment of patients with acute renal failure. Hakim RM, Wingard RL, Parker RA (1994) N Engl J Med 331(20): 1338-42
    › Primary publication · 7935703 (PubMed)
  7. Biocompatibility and risk of infection in haemodialysis patients. Himmelfarb J, Hakim RM (1994) Nephrol Dial Transplant : 138-44
    › Primary publication · 8065605 (PubMed)
  8. Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM (1994) Kidney Int 45(5): 1477-83
    › Primary publication · 8072261 (PubMed)
  9. Amino acid and albumin losses during hemodialysis. Ikizler TA, Flakoll PJ, Parker RA, Hakim RM (1994) Kidney Int 46(3): 830-7
    › Primary publication · 7996804 (PubMed)
  10. Use of a novel bioartificial liver in a patient with acute liver insufficiency. Neuzil DF, Rozga J, Moscioni AD, Ro MS, Hakim R, Arnaout WS, Demetriou AA (1993) Surgery 113(3): 340-3
    › Primary publication · 8441969 (PubMed)